Factor XI and contact activation as targets for antithrombotic therapy

E-ISSN： 1538-7836|13|8|1383-1395

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.8, 2015-08, pp. : 1383-1395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Factor Receptors as Targets for Therapy in Pediatric Brain Tumors

Pediatric Neurosurgery, Vol. 29, Iss. 1, 1998-10 ,pp. : 1-13

Karger

Access to resources Recommend Favorite

Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy

International Journal of Molecular Medicine, Vol. 29, Iss. 3, 2012-01 ,pp. : 409-415

Spandidos Publications

Access to resources Recommend Favorite

Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer

CANCER, Vol. 120, Iss. 20, 2014-10 ,pp. : 3208-3218

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor XI‐related thrombosis and the role of concentrate treatment in factor XI deficiency

HAEMOPHILIA, Vol. 21, Iss. 4, 2015-07 ,pp. : 477-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recurrent Perimesencephalic Subarachnoid Hemorrhage During Antithrombotic Therapy

By van der Worp H.

Neurocritical Care, Vol. 10, Iss. 2, 2009-04 ,pp. : 209-212

Humana Press, Inc

Access to resources Recommend Favorite